Immunopathogenesis versus Protection in Dengue Virus Infections

27Citations
Citations of this article
67Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Dengue viruses (DENV) are mosquito-borne viruses that cause significant morbidity. The existence of four serotypes of DENV with partial immunologic cross-reactivity creates the opportunity for individuals to experience multiple acute DENV infections over the course of their lifetimes. Research over the past several years has revealed complex interactions between DENV and the human innate and adaptive immune systems that can have either beneficial or detrimental influences on the outcome of infection. Further studies that seek to distinguish protective from pathological immune responses in the context of natural DENV infection, as well as clinical trials of candidate DENV vaccines, are an important part of efforts to control the global impact of this re-emerging viral disease.

Cite

CITATION STYLE

APA

Rothman, A. L., Medin, C. L., Friberg, H., & Currier, J. R. (2014, March 1). Immunopathogenesis versus Protection in Dengue Virus Infections. Current Tropical Medicine Reports. Springer Verlag. https://doi.org/10.1007/s40475-013-0009-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free